New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery

Journal of Vascular Surgery

Volumn 51, Issue 1, 2010, Pages 242-251

  Bauer, Stephen M ^a   Cayne, Neal S ^a   Veith, Frank J ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CLOPIDOGREL; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; TICLOPIDINE;

ALGORITHM; BLEEDING; BRADYCARDIA; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DEATH; DRUG EFFECT; DRUG MECHANISM; EXERCISE TEST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPOTENSION; LEE CARDIAC RISK INDEX; LOW DRUG DOSE; MORTALITY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RATING SCALE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; STROKE; UNSTABLE ANGINA PECTORIS; VASCULAR SURGERY;

ADRENERGIC BETA-ANTAGONISTS; ALGORITHMS; AMERICAN HEART ASSOCIATION; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CLINICAL PROTOCOLS; CORONARY ARTERY DISEASE; EXERCISE TEST; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL REVASCULARIZATION; PATIENT SELECTION; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; VASCULAR SURGICAL PROCEDURES;

EID: 72749096926     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.08.087     Document Type: Review

References (62)

1. Poldermans D., Hoeks S.E., and Feringa H.H. Pre-operative risk assessment and risk reduction before surgery. J Am Coll Cardiol 51 (2008) 1913-1924
2. Monahan T.S., Shrikhande G.V., Pomposelli F.B., Skillman J.J., Campbell D.R., Scovell S.D., et al. Preoperative cardiac evaluation does not improve or predict perioperative or late survival in asymptomatic diabetic patients undergoing elective infrainguinal arterial reconstruction. J Vasc Surg 41 (2005) 38-45 discussion
3. Muller J.E., Kaufmann P.G., Luepker R.V., Weisfeldt M.L., Deedwania P.C., and Willerson J.T. Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants. Circulation 96 (1997) 3233-3239
4. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
5. Mahmoudi M., Curzen N., and Gallagher P.J. Atherogenesis: the role of inflammation and infection. Histopathology 50 (2007) 535-546
6. Mangano D.T. Perioperative cardiac morbidity. Anesthesiology 72 (1990) 153-184
7. Ohtsuka T., Hamada M., Hiasa G., Sasaki O., Suzuki M., Hara Y., et al. Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 37 (2001) 412-417
8. Jenkins N.P., Keevil B.G., Hutchinson I.V., and Brooks N.H. Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. Am J Med 112 (2002) 269-274
9. Prabhu S.D., Chandrasekar B., Murray D.R., and Freeman G.L. Beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 101 (2000) 2103-2109
10. Anzai T., Yoshikawa T., Takahashi T., Maekawa Y., Okabe T., Asakura Y., et al. Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction. Cardiology 99 (2003) 47-53
11. Sipahi I., Tuzcu E.M., Wolski K.E., Nicholls S.J., Schoenhagen P., Hu B., et al. Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials. Ann Intern Med 147 (2007) 10-18
12. Schouten O., Poldermans D., Visser L., Kertai M.D., Klein J., van Urk H., et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. Am Heart J 148 (2004) 1047-1052
13. Lindenauer P.K., Pekow P., Wang K., Mamidi D.K., Gutierrez B., and Benjamin E.M. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 (2005) 349-361
14. Feringa H.H., Bax J.J., Boersma E., ertai M.D., Meij S.H., Galal W., et al. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation 114 (2006) I344-I349
15. Crisby M., Nordin-Fredriksson G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 (2001) 926-933
16. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 109 (2004) III39-III43
17. Kennedy J., Quan H., Buchan A.M., Ghali W.A., and Feasby T.E. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 36 (2005) 2072-2076
18. Paraskevas K.I., Liapis C.D., Hamilton G., and Mikhailidis D.P. Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery?. Eur J Vasc Endovasc Surg 32 (2006) 286-293
19. Paraskevas K.I., Hamilton G., Mikhailidis D.P., and Liapis C.D. Optimal medical management of peripheral arterial disease. Vasc Endovascular Surg 41 (2007) 87
20. Paraskevas K.I., Liapis C.D., Hamilton G., and Mikhailidis D.P. Are statins an option in the management of abdominal aortic aneurysms?. Vasc Endovascular Surg 42 (2008) 128-134
21. Eagle K.A., Brundage B.H., Chaitman B.R., Ewy G.A., Fleisher L.A., Hertzer N.R., et al. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 27 (1996) 910-948
22. Eagle K.A., Berger P.B., Calkins H., Chaitman B.R., Ewy G.A., Fleischmann K.E., et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery-Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 94 (2002) 1052-1064
23. Goldman L., Caldera D.L., Nussbaum S.R., Southwick F.S., Krogstad D., Murray B., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297 (1977) 845-850
24. Lee T.H., Marcantonio E.R., Mangione C.M., Thomas E.J., Polanczyk C.A., Cook E.F., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 (1999) 1043-1049
25. Boersma E., Kertai M.D., Schouten O., Bax J.J., Noordzij P., Steyerberg E.W., et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 118 (2005) 1134-1141
26. Mangano D.T., and Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 333 (1995) 1750-1756
27. L'Italien G.J., Cambria R.P., Cutler B.S., Leppo J.A., Paul S.D., Brewster D.C., et al. Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures. J Vasc Surg 21 (1995) 935-944
28. Boersma E., Poldermans D., Bax J.J., Steyerberg E.W., Thomson I.R., Banga J.D., et al. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 285 (2001) 1865-1873
29. Poldermans D., Bax J.J., Schouten O., Neskovic A.N., Paelinck B., Rocci G., et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. J Am Coll Cardiol 48 (2006) 964-969
30. Welten G.M., Schouten O., van Domburg R.T., Feringa H.H., Hoeks S.E., Dunkelgrün M., et al. The influence of aging on the prognostic value of the revised cardiac risk index for postoperative cardiac complications in vascular surgery patients. Eur J Vasc Endovasc Surg 34 (2007) 632-638
31. Hertzer N.R., Beven E.G., Young J.R., O'Hara P.J., Ruschhaupt III W.F., Graor R.A., et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199 (1984) 223-233
32. Boucher C.A., Brewster D.C., Darling R.C., Okada R.D., Strauss H.W., and Pohost G.M. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 312 (1985) 389-394
33. de Virgilio C., Wall D.B., Ephraim L., Toosie K., Donayre C., White R., et al. An abnormal dipyridamole thallium/sestamibi fails to predict long-term cardiac events in vascular surgery patients. Ann Vasc Surg 15 (2001) 267-271
34. Fleisher L.A., Beckman J.A., Brown K.A., Calkins H., Chaikof E., Fleischmann K.E., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 116 (2007) e418-e499
35. Kertai M.D., Boersma E., Bax J.J., Heijenbrok-Kal M.H., Hunink M.G., L'talien G.J., et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 89 (2003) 1327-1334
36. McFalls E.O., Ward H.B., Moritz T.E., Goldman S., Krupski W.C., Littooy F., et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351 (2004) 2795-2804
37. Poldermans D., Schouten O., Vidakovic R., Bax J.J., Thomson I.R., Hoeks S.E., et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 49 (2007) 1763-1769
38. Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., Blankensteijn J.D., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341 (1999) 1789-1794
39. Powell J.T., and POBBLE Trial Investigators. Perioperative β-blockade (Pobble) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 41 (2005) 602-609
40. Yang H., Raymer K., Butler R., Parlow J., and Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 152 (2006) 983-990
41. Devereaux P.J., Yang H., Yusuf S., Guyatt G., Leslie K., et al., POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371 (2008) 1839-1847
42. Grayburn P.A., and Hillis L.D. Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med 138 (2003) 506-511
43. Poldermans D., B E., Bax J.J., and Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative cardiac mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341 (1999) 1789-1794
44. Laufs U., La Fata V., Plutzky J., and Liao J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97 (1998) 1129-1135
45. Albert M.A., Danielson E., Rifai N., and Ridker P.M. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286 (2001) 64-70
46. Ridker P.M., Rifai N., Clearfield M., Downs J.R., Weis S.E., Miles J.S., et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344 (2001) 1959-1965
47. Kinlay S., Schwartz G.G., Olsson A.G., Rifai N., Leslie S.J., Sasiela W.J., et al. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 108 (2003) 1560-1566
48. Nissen S.E., Tuzcu E.M., Schoenhagen P., Crowe T., Sasiela W.J., Tsai J., et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352 (2005) 29-38
49. Dubey L., and Hesong Z. Role of leptin in atherogenesis. Exp Clin Cardol 11 (2006) 269-275
50. Pedersen T.R., Kjekshus J., Berg K., Haghfelt T., Faergeman O., Faergeman G., et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl 5 (2004) 81-87
51. Pedersen T.R., Kjekshus J., Pyörälä K., Olsson A.G., Cook T.J., Musliner T.A., et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). Am J Cardiol 81 (1998) 333-335
52. Poldermans D., Bax J.J., Kertai M.D., Krenning B., Westerhout C.M., Schinkel A.F., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
53. Durazzo A.E., Machado F.S., Ikeoka D.T., De Bernoche C., Monachini M.C., Puech-Leão P., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004) 967-975 discussion 75-6
54. O'Neil-Callahan K., Katsimaglis G., Tepper M.R., Ryan J., Mosby C., Ioannidis J.P., et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 45 (2005) 336-342
55. Schouten O., Hoeks S.E., Welten G.M., Davignon J., Kastelein J.J., Vidakovic R., et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 100 (2007) 316-320
56. Sillesen H. What does 'best medical therapy' really mean?. Eur J Vasc Endovasc Surg 35 (2008) 139-144
57. Taylor D.W., Barnett H.J., Haynes R.B., Ferguson G.G., Sackett D.L., Thorpe K.E., et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet 353 (1999) 2179-2184
58. Creager M.A. Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events. Vasc Med 3 (1998) 257-260
59. Liapis C.D., Bell P.R., Mikhailidis, Sivenius J., Nicolaides A., Fernandes e Fernandes J., et al. ESVS Guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Endovasc Surg 37 4 suppl (2009) 1-19
60. Payne D.A., Jones C.I., Hayes P.D., Thompson M.M., London N.J., Bell P.R., et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 109 (2004) 1476-1481
61. Visona A., Tonello D., and Zalunardo B. Antithrombotic treatment before and after peripheral artery percutaneous angioplasty. Blood Transfus 7 (2009) 18-23
62. Camerota A.J. Endovascular and surgical revascularization for patients with intermittent claudication. Am J Cardiol 87 (2001) 34-43